My Account Log in

1 option

Beyond thalidomide : birth defects explained / Janet McCredie.

Holman Biotech Commons QM691 .M374 2007
Loading location information...

Available This item is available for access.

Log in to request item
Format:
Book
Author/Creator:
McCredie, Janet.
Language:
English
Subjects (All):
Abnormalities, Human--Etiology.
Abnormalities, Human.
Thalidomide--Side effects.
Thalidomide.
Congenital Abnormalities--etiology.
Thalidomide--adverse effects.
Medical Subjects:
Congenital Abnormalities--etiology.
Thalidomide--adverse effects.
Physical Description:
xii, 418 pages : illustrations (partly color) ; 26 cm
Place of Publication:
London : Royal Society of Medicine Press, [2007]
Summary:
How do birth defects happen? What goes wrong in the embryo? These perennial questions were brought into sharp focus in the wake of the thalidomide catastrophe (1958-1962). How did thalidomide mutilate the embryo? Despite research efforts, these questions have remained unanswered. The author, a diagnostic radiologist, recognized that there were some clues to a possible answer in the radiographs of thalidomide children, although these had not been fully analysed. Taking a new approach to the disordered anatomy, she found that the character and the distribution of skeletal defects was inconsistent with primary bone disease, which had been the current thinking, but indicated primary damage to embryonic sensory nerves (neural crest), with subsequent failure of formation of bones and joints. Thalidomide is a notorious sensory neurotoxin in adults, and her analysis pointed to the same target tissue in the embryo. The neural crest theory, however, extends beyond thalidomide and could explain the majority of non-genetic birth defects, anatomically similar to those caused by thalidomide, but hitherto unexplained. Thalidomide was the key that opened the lock to reveal the mechanism underlying many, but not all, congenital malformations - its recent revival as a therapeutic agent adds urgency to the need to clarify its mode of action. Beyond Thalidomide examines the neural crest theory in breadth and depth, incorporating evidence from clinical medicine, radiology, biology, pharmacology, neurology, neuroanatomy and neuropathology. Key publications, some now out of print, are restored to their rightful places in the thalidomide saga and background information is provided to help the general reader gain a better understanding of the sciences involved. It will be of particular interest to those involved with birth defects - obstetricians, neonatologists, paediatricians - and also neurologists, scientists in teratology and developmental biology, and thalidomiders themselves.
Contents:
Foreword: Lord Walton of Detchant vii
1 The thalidomide epidemic 1
2 Pharmacology of thalidomide: Interaction with the human embryo 11
3 Animal studies 23
4 Thalidomide polyneuropathy 39
5 Clinical radiology 57
6 Terminology, classification and the rejection of authority 63
7 The pattern of the disease: First radiological analysis (Sydney) 69
8 Verification of the disease pattern: Second radiological analysis (London) 87
9 Congenital reductions of the radius 91
10 Congenital dislocation 101
11 Congenital synostosis 115
12 The hypothesis of neural crest injury 125
13 The neural crest 139
14 Neurotrophism 157
15 Nerve in limb bud 169
16 Regeneration and embryogenesis 185
17 Neural crest ablation and limb morphogenesis 197
18 Thalidomide deformities and their nerve supply: First morphometric study in rabbits 211
19 Thalidomide deformities and their nerve supply: Second morphometric study in rabbits 229
20 The sensory nerve supply of bone 237
21 The sclerotomes 245
22 Sclerotome aplasia/subtraction 257
23 Sclerotome aplasia/subtraction in 203 cases 269
24 Radial/tibial dysmelia: Limb reductions typical of thalidomide 281
25 Associated internal malformations and their embryology 295
26 Neurotomes and multiple malformation syndromes 317
27 Hands and feet in thalidomide embryopathy: Histology and sclerotomes in the digits 333
28 Other disorders of similar sclerotomes 351
29 Segmental and truncal neuropathies in sclerotomes not affected by thalidomide 365
30 Review of actions of thalidomide 387
31 Conclusion: Beyond thalidomide 399.
Notes:
Includes bibliographical references and index.
ISBN:
1853157414
9781853157417
OCLC:
182662820

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account